Skip to content

Ultrasound guided management of renal failure in Cirrhosis

VExUS Assisted Management of Acute Kidney injury in Cirrhosis (VAMAS Study) - VAMAS

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088973
Enrollment
120
Registered
2025-06-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K74- Fibrosis and cirrhosis of liver

Interventions

Intervention1: POCUS Assisted Therapy: POCUS Protocol Done for Volume characterization and congestion assessment (VeXUS) i. Inferior Vena Cava (IVC): Measure diameter and collapsibility index to asse

Sponsors

INHS Kalyani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients of chronic liver disease (diagnosed by clinical, biochemical, imaging criteria) presenting with Acute kidney injury per KDIGO criteria

Exclusion criteria

Exclusion criteria: 1.Established chronic kidney disease (as per KDIGO criteria) stage 3-5 2.Patients on dialysis 3.Patients on mechanical ventilator 4.Conditions in whom technically POCUS could not be done 5.Non Cooperative patient

Design outcomes

Primary

MeasureTime frame
1.Recovery of AKI (?20 % decrease ( partial recovery) in serum creatinine or return to baseline) by day 7 2.Duration in days to attain renal recovery ( return of creatinine level to partial or complete recovery) Timepoint: 7 days

Secondary

MeasureTime frame
1.30-day mortality 2.Therapy adjustments (e.g., fluids, use of diuretic, Inj albumin, day of hospitalization terlipressin use) compared between groups 3.Length of hospitalization Timepoint: Onset, 7 days, 30 days

Countries

India

Contacts

Public ContactVineet Behera

INHS Kalyani

vineetbeheraaiims@gmail.com9673470724

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026